Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas

		Keywords:		Vandetanib , Etoposide

		Phase:		Phase 1

		Treatment ID#s:		VT1940 NCT00613223

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		09/05/2009

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme Gliosarcoma Oligodendroglioma High Grade


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		The Brain Tumor Center at Duke Henry Friedman, MD Contact: Dr. Henry S. Friedman Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- Phone:(919)684-5301 Fax: (919)684-6674 Click here to send an email Website: www.cancer.duke.edu/btc

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By